vcl-cb01
Vaccineexperimental
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Jan 1, 2006 (NCT00285259)
Timeline
Indications
Mechanism of action
- CytomegalovirusImmunity, active
Cytomegalovirus immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- vcl-cb01
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00373412 | Phase 1 | Oct 1, 2006 | University of California, San Francisco, Vical |
| NCT00285259 | Phase 2 | Jan 1, 2006 | Astellas, Vical |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Vical | For profit | 2 | 0 | 2 | 2006 |
| Astellas | For profit | 1 | 1 | 1 | 2006 |
| University of California, San Francisco | Academic/Hospital | 1 | 1 | 1 | 2006 |
3 organizations
Page 1 / 1